LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
U.S Orthopedic Biomaterials Market
http://www.reportbuyer.com/pharma_healthcare/biotechnology/u_s_orthopedic_biomaterials_market.html
In 2012, the U.S. market for orthopedic biomaterials was valued at almost $3.4 billion. This total comprises eight different market segments.
The orthopedic biomaterials market has undergone a shift away from certain devices and towards new areas and medical devices. There is still tremendous potential for growth, especially in the younger market segments such as stem cells and concentration systems. Conversely, some products that previously experienced rapid market growth have now entered maturity, but even these markets are sustained by continued product evolution.
Scope:
This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S.
Report Contents:
Competitor Analysis
Identified Strategic Opportunities
Market Overview by Segment & Country
Trend Analysis by Segment & Country
Market Drivers & Limiters
Mergers & Acquisitions
Customer Feedback and Market Monitoring
Main Segments Included:
Orthopedic Bone Graft Substitute
Orthopedic Growth Factor
Orthopedic Stem Cell
Orthopedic Cell Therapy
Orthopedic Hyaluronic Acid Viscosupplementation
Orthopedic Tendon Graft
Orthopedic Cartilage Repair
Spinal Machined Bone Allograft
Sub-Segments Included:
Autograft
Standard Allograft
Demineralized Bone Matrix
Synthetic Bone Graft
Xenograft
BMP-2
BMP-7
Human Embryonic Stem Cells
Mesengchymal Stem Cells
Lumbar Spine Stem Cells
Cervical Spine Stem Cells
Platelet-Rich Plasma
Orthopedic Concentrated Bone Marrow Aspirate
Single-Injection
Three-Injection Cycle
Three/Five-Injection Cycle
BTB Graft
Soft Tissue Grafts
Ligament and Tendon Synthetic Graft
Osteochondral Allograft
Autologous Chondrocyte Implantation
Meniscal Allograft Tansplantation
ALIF Machined Bone Allograft
PLIF Machined Bone Allograft
TLIF Machined Bone Allograft
CIF Machined Bone Allograft
Companies Included:
Sanofi-Aventis/Genzyme
Bioventus
DePuy Synthes
Medtronic
Musculoskeletal Transplant Foundation
Stryker
RTI Biologics
NuVasive
Orthofix
LifeNet Health
AlloSource
Integra LifeSciences
Anika Therapeutics
Biomet
Ferring Pharmaceuticals
Exactech
Baxter
Harvest Technologies
Cytomedix
Wright Medical
Community Tissue Services
Olympus Biotech
Fidia
Arteriocyte
Alphatec Spine
Joint Restoration Foundation
University of Miami Tissue Bank
Celling Biosciences
Zimmer
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our "ground up" approach, which includes primary and secondary research methods.
TABLE OF CONTENTS
LIST OF FIGURES IX
LIST OF CHARTS XV
1. EXECUTIVE SUMMARY 1
1.1 ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1
1.2 ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET 2
1.3 ORTHOPEDIC GROWTH FACTOR MARKET 3
1.4 ORTHOPEDIC STEM CELL MARKET 4
1.5 ORTHOPEDIC CELL THERAPY MARKET 5
1.6 ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 6
1.7 ORTHOPEDIC TENDON GRAFT MARKET 7
1.8 ORTHOPEDIC CARTILAGE REPAIR MARKET 8
1.9 COMPETITIVE ANALYSIS 9
2. RESEARCH METHODOLOGY 11
2.1 RESEARCH SCOPE 11
2.2 IDATA'S 9-STEP METHODOLOGY 11
Step 1: Project Initiation & Team Selection 12
Step 2: Prepare Data Systems and Perform Secondary Research 13
Step 3: Preparation for Interviews & Questionnaire Design 14
Step 4: Performing Primary Research 14
Step 5: Research Analysis: Establishing Baseline Estimates 16
Step 6: Market Forecast and Analysis 17
Step 7: Identify Strategic Opportunities 19
Step 8: Final Review and Market Release 20
Step 9: Customer Feedback and Market Monitoring 20
3. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 21
3.1 INTRODUCTION 21
3.1.1 Bone Graft Substitutes 22
3.1.2 Growth Factors 22
3.1.3 Orthopedic Stem Cell Therapy 23
3.1.4 Cell Therapies 23
3.1.5 Hyaluronic Acid Viscosupplementation 24
3.1.6 Tendon Grafts 24
3.1.7 Cartilage Repair 24
3.2 MARKET OVERVIEW 25
3.3 TREND ANALYSIS 30
3.4 MARKET DRIVERS AND LIMITERS 33
3.4.1 Market Drivers 33
3.4.2 Market Limiters 33
3.5 COMPETITIVE ANALYSIS 36
3.5.1 Leading Competitors 36
3.6 MARKET CONCENTRATION 42
3.7 MERGERS AND ACQUISITIONS 44
4. ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET 49
4.1 INTRODUCTION 49
4.2 MARKET SEGMENTATION 50
4.2.1 By Indication 50
4.2.1.1 Spine 50
4.2.1.2 Thoracolumbar Spine 50
4.2.1.3 Cervical Spine 50
4.2.1.4 Trauma 51
4.2.1.5 Extremities 51
4.2.2 By Material 51
4.2.2.1 Autograft 51
4.2.2.2 Standard Allograft 51
4.2.2.3 Demineralized Bone Matrix 51
4.2.2.4 Synthetic 52
4.2.2.5 Xenograft 52
4.3 PROCEDURES 53
4.3.1 Bone Graft Substitute Procedures 53
4.4 UNITS PER PROCEDURE 54
4.5 MARKET OVERVIEW 56
4.5.1 Bone Graft Substitute Market by Material 58
4.5.2 Bone Graft Substitute Market by Indication 61
4.6 MARKET ANALYSIS & FORECAST 64
4.6.1 Bone Graft Substitute Market by Material 64
4.6.1.1 Total Allograft Bone Graft Substitute Market 64
4.6.1.2 Total Demineralized Bone Matrix (DBM) Bone Graft Substitute Market 79
4.6.1.3 Total Synthetic Bone Graft Substitute Market 96
4.6.2 Bone Graft Substitute Market by Indication 111
4.6.2.1 Spine Bone Graft Substitute Market 111
4.6.2.2 Cervical Spine Bone Graft Substitute Market 113
4.6.2.3 Thoracolumbar Spine Bone Graft Substitute Market 115
4.6.2.4 Trauma Bone Graft Substitute Market 117
4.6.2.5 Non-union Trauma Fracture Bone Graft Substitute Market 119
4.6.2.6 Fresh Fracture Trauma Bone Graft Substitute Market 120
4.6.2.7 Large Joint Reconstruction Bone Graft Substitute Market 121
4.6.2.8 Hip Large Joint Reconstruction Bone Graft Substitute Market 123
4.6.2.9 Knee Large Joint Reconstruction Bone Graft Substitute Market 124
4.6.2.10 Foot Reconstruction Bone Graft Substitute Market 125
4.6.2.11 Craniomaxillofacial Bone Graft Substitute Market 127
4.6.2.12 Oncology Bone Graft Substitute Market 129
4.7 MARKET DRIVERS AND LIMITERS 131
4.7.1 Market Drivers 131
4.7.1.1 Allograft Bone Graft Substitute Market 131
4.7.1.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market 131
4.7.1.3 Synthetic Bone Graft Substitute Market 132
4.7.2 Market Limiters 134
4.7.2.1 Allograft Bone Graft Substitute Market 134
4.7.2.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market 134
4.7.2.3 Synthetic Bone Graft Substitute Market 135
4.8 COMPETITIVE ANALYSIS 136
4.8.1 Allograft Bone Graft Substitute Market 136
4.8.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market 140
4.8.3 Synthetic Bone Graft Substitute Market 143
4.8.4 Total Bone Graft Substitute Market 147
5. ORTHOPEDIC GROWTH FACTOR MARKET 149
5.1 INTRODUCTION 149
5.2 MARKET OVERVIEW 149
5.2.1 BMP-2 (Medtronic) 150
5.2.2 BMP-7 (Olympus Biomaterials) 150
5.2.3 Reimbursement 151
5.2.4 Future Indications 151
5.3 MARKET ANALYSIS & FORECAST 152
5.4 MARKET DRIVERS AND LIMITERS 154
5.4.1 Market Drivers 154
5.4.2 Market Limiters 154
5.5 COMPETITIVE ANALYSIS 157
6. ORTHOPEDIC STEM CELL MARKET 159
6.1 INTRODUCTION 159
6.2 MARKET OVERVIEW 159
6.2.1 Lineage 159
6.2.1.1 Human Embryonic Stem Cells (hESC) 159
6.2.1.2 Mesenchymal Stem Cells (MSC) 160
6.2.2 Legislation 160
6.2.3 Other Therapeutic Applications 160
6.3 MARKET ANALYSIS & FORECAST 161
6.3.1.1 Lumbar Spine Stem Cell Market 165
6.3.1.2 Cervical Spine Stem Cell Market 167
6.4 DRIVERS AND LIMITERS 169
6.4.1 Market Drivers 169
6.4.2 Market Limiters 169
6.5 COMPETITIVE ANALYSIS 171
7. ORTHOPEDIC CELL THERAPY MARKET 175
7.1 INTRODUCTION 175
7.1.1 Platelet-Rich Plasma 176
7.1.2 Concentrated Bone Marrow Aspirate 177
7.2 MARKET OVERVIEW 178
7.3 MARKET ANALYSIS & FORECAST 182
7.3.1 Platelet-Rich Plasma Market 182
7.3.1.1 Spinal Platelet-Rich Plasma Market 187
7.3.1.2 Soft Tissue Reconstruction Platelet-Rich Plasma Market 188
7.3.1.3 Joint Reconstruction Platelet-Rich Plasma Market 189
7.3.1.4 Cardiac Surgery Platelet-Rich Plasma Market 190
7.3.1.5 Other Platelet-Rich Plasma Markets 191
7.3.2 Orthopedic Concentrated Bone Marrow Aspirate Market 192
7.3.2.1 Spine Concentrated Bone Marrow Aspirate Market 197
7.3.2.2 Trauma Concentrated Bone Marrow Aspirate Market 198
7.3.2.3 Joint Reconstruction Concentrated Bone Marrow Aspirate Market 199
7.3.2.4 Other Concentrated Bone Marrow Aspirate Market 200
7.4 MARKET DRIVERS AND LIMITERS 201
7.4.1 Market Drivers 201
7.4.2 Market Limiters 202
7.5 COMPETITIVE ANALYSIS 204
8. ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 207
8.1 INTRODUCTION 207
8.1.1 Benefits of Viscosupplementation 208
8.1.2 Synovial Fluid 208
8.1.3 Product Types 209
8.1.3.1 Single-Injection Products 209
8.1.3.2 Three-Injection Cycle Products 209
8.1.3.3 Three/Five-Injection Cycle Products 209
8.1.4 Reimbursement 209
8.2 MARKET OVERVIEW 210
8.3 MARKET ANALYSIS & FORECAST 214
8.3.1 Single-Injection Hyaluronic Acid Viscosupplementation Market 214
8.3.2 Three-Injection Hyaluronic Acid Viscosupplementation Market 216
8.3.3 Five-Injection Hyaluronic Acid Viscosupplementation Market 218
8.4 MARKET DRIVERS AND LIMITERS 220
8.4.1 Market Drivers 220
8.4.2 Market Limiters 221
8.5 COMPETITIVE ANALYSIS 223
9. ORTHOPEDIC TENDON GRAFT MARKET 227
9.1 INTRODUCTION 227
9.2 MARKET OVERVIEW 228
9.2.1 BTB 228
9.2.2 Soft Tissue Grafts 228
9.2.3 Allografted Tendons 228
9.2.4 Ligament and Tendon Synthetic Grafts 229
9.3 MARKET ANALYSIS & FORECAST 230
9.3.1 ACL/PCL Reconstruction Procedures 230
9.3.2 ACL/PCL Allograft Tendon Market 232
9.4 DRIVERS AND LIMITERS 234
9.4.1 Market Drivers 234
9.4.2 Market Limiters 235
9.5 COMPETITIVE ANALYSIS 236
10. ORTHOPEDIC CARTILAGE REPAIR MARKET 239
10.1 INTRODUCTION 239
10.1.1 Anatomy 239
10.1.2 Methods for Cartilage Repair 240
10.1.2.1 Osteochondral Allograft Transfer 240
10.1.2.2 Autologous Chondrocyte Implantation (ACI) 240
10.1.2.3 Meniscal Allograft Transplantation 240
10.2 MARKET OVERVIEW 241
10.3 MARKET ANALYSIS AND FORECAST 245
10.3.1 Osteochondral Cartilage Allograft Market 246
10.3.2 Meniscal Allograft Market 247
10.3.3 Autologous Chondrocyte Implantation Market 248
10.4 MARKET DRIVERS AND LIMITERS 249
10.4.1 Market Drivers 249
10.4.2 Market Limiters 249
10.5 COMPETITIVE ANALYSIS 251
11. SPINAL MACHINED BONE ALLOGRAFT MARKET 255
11.1 INTRODUCTION 255
11.1.1 Machined Bone 257
11.2 MARKET OVERVIEW 258
11.3 MARKET ANALYSIS & FORECAST 261
11.3.1 Spinal Machined Bone Allograft Market by Segment 261
11.3.1.1 ALIF Machined Bone Allograft Market 262
11.3.1.2 PLIF Machined Bone Allograft Market 263
11.3.1.3 TLIF Machined Bone Allograft Market 264
11.3.1.4 CIF Machined Bone Allograft Market 265
11.4 MARKET DRIVERS AND LIMITERS 266
11.4.1 Market Drivers 266
11.4.2 Market Limiters 267
11.5 COMPETITIVE ANALYSIS 270
ABBREVIATIONS 273
Read the full report:
U.S Orthopedic Biomaterials Market
http://www.reportbuyer.com/pharma_healthcare/biotechnology/u_s_orthopedic_biomaterials_market.html
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article